Elrose Labs Conzerol Zero Cream Recall: CPG Deviations Risk
Elrose Labs recalls Conzerol Zero topical cream due to cGMP deviations. Affected units have NDC 70223-001-06. No specific remedy stated in official notice.
Recall notice
cGMP Deviations
Contact the company
What happened, in plain English
Elrose Labs is recalling Conzer: a topical cream for molluscum contagiosum. The recall is due to cGMP deviations, which means the product may not meet quality standards. This could affect safety and effectiveness. Read more at govinfonow.com/recall/40713-elrose-labs-conzerol-zero-cream-recall-cpg-deviations-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/40713-elrose-labs-conzerol-zero-cream-recall-cpg-deviations-risk · Updated October 7, 2026 · FDA enforcement record: FDA #D-0621-2018
Cite this page
“Elrose Labs Conzerol Zero Cream Recall: CPG Deviations Risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40713-elrose-labs-conzerol-zero-cream-recall-cpg-deviations-risk. Based on FDA recall #D-0621-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0621-2018%22&limit=1).
Why it’s dangerous
cGMP deviations refer to failures in manufacturing quality control processes. This could mean the cream doesn't meet safety and effectiveness standards, potentially causing harm to users.
Who’s affected
People who purchased or use Conzerol Zero cream from Elrose Labs. Those with molluscum contagiosum infections may be at higher risk if the product is unsafe.
How to tell if you have this one
Check for the product name 'Conzerol Zero', net weight 22g, and NDC number 70223-001-06. The product was sold by Elrose Labs in Sanford, Florida.
- Brand
Elrose Labs- Category
Drug
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide.
| Recall number | Product, codes & lots |
|---|---|
| D-0621-2018 | Conzerol zero molluscum contagiosum, Topical Cream, Net weight 0.78 (22g), Elrose Labs, Sanford Fl 32771 USA --- NDC 70223-001-06; All product within expiry |
| D-0622-2018 | Molleave, 2 oz bottle, OTC, Manufactured for Elrose Labs, Inc.; All product within expiry |
| D-0623-2018 | Conzerol (antipoxin) H2O2 Gel, Hydrogen Peroxide Gel 3%, 1.5 oz. tube, OTC, Manufactured for Elrose Labs, Inc., Sanford, FL; All product within expiry |
What to do — step by step
Check Product Details
Look for the NDC number 70223-001-06 on the product label.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.7 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0621-2018 (March 28, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0621-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.